125 related articles for article (PubMed ID: 15154022)
1. Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine?
Leo RJ; Barkin RL
Prim Care Companion J Clin Psychiatry; 2003 Jun; 5(3):118-123. PubMed ID: 15154022
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
3. A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.
Kremer M; Yalcin I; Goumon Y; Wurtz X; Nexon L; Daniel D; Megat S; Ceredig RA; Ernst C; Turecki G; Chavant V; Théroux JF; Lacaud A; Joganah LE; Lelievre V; Massotte D; Lutz PE; Gilsbach R; Salvat E; Barrot M
J Neurosci; 2018 Nov; 38(46):9934-9954. PubMed ID: 30249798
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms.
McIntyre RS; Konarski JZ
Expert Opin Pharmacother; 2005 May; 6(5):707-13. PubMed ID: 15934897
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.
Spielmans GI
Psychother Psychosom; 2008; 77(1):12-6. PubMed ID: 18087203
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Hu B; Doods H; Treede RD; Ceci A
Neurosci Lett; 2016 Apr; 619():162-7. PubMed ID: 26987721
[TBL] [Abstract][Full Text] [Related]
7. The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.
Fishbain DA; Detke MJ; Wernicke J; Chappell AS; Kajdasz DK
Curr Med Res Opin; 2008 Nov; 24(11):3105-15. PubMed ID: 18828958
[TBL] [Abstract][Full Text] [Related]
8. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
9. [Medication of the month. Duloxetine (Cymbalta)].
Pitchot W
Rev Med Liege; 2006 Nov; 61(11):787-90. PubMed ID: 17191749
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine for somatic pain associated with physical illness: a review.
Masand PS; Narasimhan M; Patkar AA
Prim Care Companion J Clin Psychiatry; 2006; 8(3):122-30. PubMed ID: 16912814
[TBL] [Abstract][Full Text] [Related]
11. Prescribing patterns and safety monitoring of duloxetine using the Danish Register of Medicinal Product Statistics as a source.
Johansen AN; Stenzhorn AA; Rosenzweig M; Thirstrup S; Gazerani P
Scand J Public Health; 2013 Dec; 41(8):866-73. PubMed ID: 23885111
[TBL] [Abstract][Full Text] [Related]
12. Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system.
Minami K; Tamano R; Kasai E; Oyama H; Hasegawa M; Shinohara S; Asaki T
Eur J Pain; 2018 Feb; 22(2):355-369. PubMed ID: 28952182
[TBL] [Abstract][Full Text] [Related]
13. Management of depression in the presence of pain symptoms.
Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine for the treatment of fibromyalgia.
Acuna C
Drugs Today (Barc); 2008 Oct; 44(10):725-34. PubMed ID: 19137126
[TBL] [Abstract][Full Text] [Related]
15. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
Murai N; Fushiki H; Honda S; Murakami Y; Iwashita A; Irie M; Tamura S; Nagakura Y; Aoki T
Neuroscience; 2015 Mar; 289():262-9. PubMed ID: 25595980
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder.
Muscatello MRA; Zoccali RA; Pandolfo G; Mangano P; Lorusso S; Cedro C; Battaglia F; Spina E; Bruno A
Front Psychiatry; 2019; 10():772. PubMed ID: 31749717
[No Abstract] [Full Text] [Related]
18. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.
Delgado PL
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():16-21. PubMed ID: 24921678
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine in the treatment of major depression and other psychiatric disorders.
Blanco C; Okuda M; Rosenthal H; Lewis-Fernandez R
Expert Rev Clin Pharmacol; 2008 Mar; 1(2):195-205. PubMed ID: 24422645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
